Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous paracetamol versus dexamethasone for acute migraine in the emergency department
IRCT20240619062184N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in migraine comparing Intravenous Apotel with Intravenous dexamethasone (2 arms). Primary endpoints: Pain response, Time to relief after injection and 3 more. Started Jul 2024; status: completed.
02
Drugs
acetaminophendexamethasone
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20240619062184N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240619062184N1.